Clinical evidence reported after these guidelines had been published showed that IL-1α and IL-1β mediate the pathophysiology of RP through the inappropriate induction and activation, respectively, of the innate immune system in a self-perpetuating cycle of autoinflammation.13 This evidence concerns the gene IL1A and retinitis pigmentosa 1.